NeoCura Bio-Medical Technology Co., Ltd.
PrivateLast Round
Series A
Extension
Dec 21, 2021
Total Funding Raised
$116.65M
Company Overview
NeoCura Bio-Medical Technology Co., Ltd. is a biotechnology company that develops an artificial intelligence-driven RNA technology platform for the research and development of innovative tumor vaccines and immunotherapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeoCura Bio-Medical Technology Co., Ltd. Comparables
Compare NeoCura Bio-Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Likang Life Sciences | 85% | |
| myNEO Therapeutics | 83% | |
| Evaxion A/S | 79% |
NeoCura Bio-Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 21, 2021 | ||||
| Series A | Dec 24, 2020 |
NeoCura Bio-Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A |
| IDG Capital | Series A |
| PICC Capital Insurance Asset Management | Series A Extension |
| Kunlun Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 27, 2026
Added Lastoria, a medical devices startup, as a customer.
- Dec 21, 2021
$78M round led by PICC Capital and Zhou Yahui.
NeoCura Bio-Medical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NeoCura Bio-Medical Technology Co., Ltd.'s valuation, stock price, and market status.
Is NeoCura Bio-Medical Technology Co., Ltd. a public or private company?
NeoCura Bio-Medical Technology Co., Ltd. is a private company.
What is the current stock price of NeoCura Bio-Medical Technology Co., Ltd.?
NeoCura Bio-Medical Technology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is NeoCura Bio-Medical Technology Co., Ltd. worth (valuation)?
Valuation information for NeoCura Bio-Medical Technology Co., Ltd. is not publicly available.
Can I buy NeoCura Bio-Medical Technology Co., Ltd. stock?
NeoCura Bio-Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NeoCura Bio-Medical Technology Co., Ltd.'s last funding round?
NeoCura Bio-Medical Technology Co., Ltd.'s most recent funding round was Series A Extension on December 21, 2021.
Who are the main investors in NeoCura Bio-Medical Technology Co., Ltd.?
Key investors in NeoCura Bio-Medical Technology Co., Ltd. include PICC Capital Insurance Asset Management.
Will NeoCura Bio-Medical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for NeoCura Bio-Medical Technology Co., Ltd..
How can I track NeoCura Bio-Medical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NeoCura Bio-Medical Technology Co., Ltd.'s secondary market activity and sign up for updates.